Zyla Life Sciences

CIK 1586105 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Zyla Life Sciences.

Recent SEC filings

FiledFormAccession number
Jan 29, 2021SC 13G/A0001104659-21-009086
Jun 1, 202015-12B0001104659-20-068389
May 22, 202040001209191-20-031694
May 22, 2020SC 13D/A0001193125-20-150077
May 21, 202040001104659-20-064785
May 21, 202040001104659-20-064788
May 21, 202040001104659-20-064791
May 21, 202040001104659-20-064799
May 21, 202040001104659-20-064795
May 21, 202040001104659-20-064792
May 21, 202040001104659-20-064800
May 21, 202040001104659-20-064794
May 20, 20208-K0001104659-20-064291
May 20, 20208-K0001104659-20-064288
May 20, 2020S-8 POS0001104659-20-064283
May 20, 2020S-8 POS0001104659-20-064277
May 20, 2020250001104659-20-064287
May 15, 20204250001104659-20-062632
May 15, 20208-K0001104659-20-062073
May 15, 20204250001104659-20-062589
May 15, 20208-K0001104659-20-062631
May 14, 202010-Q0001558370-20-006622
May 1, 2020DEFA14A0001104659-20-055015
Apr 28, 20204/A0001179110-20-005217
Apr 28, 202010-K/A0001558370-20-004399